Cargando…
Inflammation, atrial fibrillation, and the potential role for colchicine therapy
Increasing evidence suggests that the “NACHT-LRR and PYD domain-containing protein 3” (NLRP3) inflammasome plays an important role in atherosclerotic cardiovascular disease (ASCVD). Recent preclinical evidence has suggested that the NLRP3 inflammasome may play a prominent role in the pathogenesis of...
Autores principales: | Varghese, Bibin, Feldman, David I., Chew, Christopher, Valilis, Eva, Blumenthal, Roger S., Sharma, Garima, Calkins, Hugh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322795/ https://www.ncbi.nlm.nih.gov/pubmed/34337581 http://dx.doi.org/10.1016/j.hroo.2021.03.011 |
Ejemplares similares
-
Cryoablation for atrial fibrillation
por: Andrade, Jason G.
Publicado: (2020) -
American Indians and atrial fibrillation
por: Sanchez, José M., et al.
Publicado: (2022) -
Colchicine in atrial fibrillation: are old trees in bloom?
por: Zhan, Yujia, et al.
Publicado: (2023) -
Postoperative atrial fibrillation in patients with left atrial myxoma
por: Sahin, Muslum, et al.
Publicado: (2015) -
Atrial remodeling and atrial fibrillation in acquired forms of cardiovascular disease
por: Jansen, Hailey J., et al.
Publicado: (2020)